Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice

544 indexed citations
published 2003

Countries where authors are citing Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice

Specialization
Citations

This map shows the geographic impact of Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice more than expected).

Fields of papers citing Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice.

About Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice

This paper, published in 2003, received 544 indexed citations . Written by Taku Okazaki, Yoshimasa Tanaka, Ryosuke Nishio, Tamotsu Mitsuiye, Akira Mizoguchi, Jian Wang, Masayoshi Ishida, Hiroshi Hiai, Akira Matsumori and Nagahiro Minato covering the research area of Molecular Biology and Cardiology and Cardiovascular Medicine. It is primarily cited by scholars working on Oncology (300 citations), Cardiology and Cardiovascular Medicine (239 citations) and Immunology (217 citations). Published in Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1038/nm955.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026